112 related articles for article (PubMed ID: 25061572)
1. Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer.
Kwak YK; Lee JH; Lee MA; Chun HG; Kim DG; You YK; Hong TH; Jang HS
Radiat Oncol J; 2014 Jun; 32(2):49-56. PubMed ID: 25061572
[TBL] [Abstract][Full Text] [Related]
2. Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy.
Kim YJ; Koh HK; Chie EK; Oh DY; Bang YJ; Nam EM; Kim K
Int J Clin Oncol; 2017 Dec; 22(6):1069-1075. PubMed ID: 28477059
[TBL] [Abstract][Full Text] [Related]
3. Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer.
Yang GY; Malik NK; Chandrasekhar R; Ma WW; Flaherty L; Iyer R; Kuvshinoff B; Gibbs J; Wilding G; Warren G; May KS
J Gastrointest Oncol; 2013 Dec; 4(4):361-9. PubMed ID: 24294507
[TBL] [Abstract][Full Text] [Related]
4. Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience.
Malik NK; May KS; Chandrasekhar R; Wee W; Flaherty L; Iyer R; Gibbs J; Kuvshinoff B; Wilding G; Warren G; Yang GY
J Gastrointest Oncol; 2012 Dec; 3(4):326-34. PubMed ID: 23205309
[TBL] [Abstract][Full Text] [Related]
5. Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study.
Choi Y; Oh DY; Kim K; Chie EK; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Ha SW; Bang YJ
Cancer Res Treat; 2016 Jul; 48(3):1045-55. PubMed ID: 26511805
[TBL] [Abstract][Full Text] [Related]
6. Intensity modulated radiotherapy for locally advanced and metastatic pancreatic cancer: a mono-institutional retrospective analysis.
Wang Z; Ren ZG; Ma NY; Zhao JD; Zhang Z; Ma XJ; Long J; Xu J; Jiang GL
Radiat Oncol; 2015 Jan; 10():14. PubMed ID: 25575617
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer.
Shinchi H; Maemura K; Mataki Y; Kurahara H; Sakoda M; Ueno S; Hiraki Y; Nakajo M; Natsugoe S; Takao S
J Hepatobiliary Pancreat Sci; 2012 Mar; 19(2):152-8. PubMed ID: 21647560
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of neutrophil-to-lymphocyte ratio in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
Park EY; Kim YS; Choi KH; Song JH; Lee HC; Hong SH; Kang JH
Radiat Oncol J; 2019 Sep; 37(3):166-175. PubMed ID: 31591864
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
10. The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer.
Sakin A; Sahin S; Atci MM; Sakin A; Yasar N; Geredeli C; Aksaray F; Cihan S
Pulmonology; 2021; 27(1):26-34. PubMed ID: 31839507
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of volume-based FDG PET/CT parameters in patients with locally advanced pancreatic cancer treated with chemoradiation therapy.
Choi HJ; Lee JW; Kang B; Song SY; Lee JD; Lee JH
Yonsei Med J; 2014 Nov; 55(6):1498-506. PubMed ID: 25323885
[TBL] [Abstract][Full Text] [Related]
12. Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non-Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical Trial.
Bi N; Liang J; Zhou Z; Chen D; Fu Z; Yang X; Feng Q; Hui Z; Xiao Z; Lv J; Wang X; Zhang T; Wang X; Deng L; Wang W; Wang J; Liu L; Hu C; Wang L
JAMA Netw Open; 2019 Dec; 2(12):e1918070. PubMed ID: 31851351
[TBL] [Abstract][Full Text] [Related]
13. Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer.
Hiroshima Y; Fukumitsu N; Saito T; Numajiri H; Murofushi KN; Ohnishi K; Nonaka T; Ishikawa H; Okumura T; Sakurai H
Radiother Oncol; 2019 Jul; 136():37-43. PubMed ID: 31015127
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer.
Chadha AS; Kocak-Uzel E; Das P; Minsky BD; Delclos ME; Mahmood U; Guha S; Ahmad M; Varadhachary GR; Javle M; Katz MH; Fleming JB; Wolff RA; Crane CH; Krishnan S
Acta Oncol; 2015 Jul; 54(7):971-8. PubMed ID: 25608822
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of definitive concurrent chemoradiotherapy using paclitaxel plus oxaliplatin in unresectable locally advanced esophageal cancer: a prospective phase II trial.
Song T; Zhang X; Fang M; Zhao R; Wu S
Cancer Med; 2016 Dec; 5(12):3371-3377. PubMed ID: 27925455
[TBL] [Abstract][Full Text] [Related]
16. Long Term Outcomes of Preoperative versus Postoperative Concurrent Chemoradiation for Locally Advanced Rectal Cancer: Experience from Ramathibodi Medical School in Thailand.
Darunikorn P; Puataweepong P; Dhanachai M; Dangprasert S; Swangsilpa T; Sitathanee C; Jiarpinitnun C; Pattaranutaporn P; Boonyawan K; Chansriwong P
Asian Pac J Cancer Prev; 2015; 16(16):7315-9. PubMed ID: 26514530
[TBL] [Abstract][Full Text] [Related]
17. A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer.
Gupta A; Roy S; Majumdar A; Hazra A; Mallik C
Indian J Med Paediatr Oncol; 2014 Jan; 35(1):54-9. PubMed ID: 25006285
[TBL] [Abstract][Full Text] [Related]
18. Radical radiotherapy or chemoradiotherapy for inoperable, locally advanced, non-small cell lung cancer: Analysis of patient profile, treatment approaches, and outcomes for 213 patients at a tertiary cancer center.
Shrimali RK; Nallathambi C; Saha A; Das A; Prasath S; Mahata A; Arun B; Mallick I; Achari R; Dabkara D; Thambudorai R; Chatterjee S
Indian J Cancer; 2018; 55(2):125-133. PubMed ID: 30604722
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of concurrent cisplatin and 5-flurouracil chemotherapy and radiation therapy for locally advanced cancer of the uterine cervix.
Choi IJ; Cha MS; Park ES; Han MS; Choi Y; Je GH; Kim HH
J Gynecol Oncol; 2008 Jun; 19(2):129-34. PubMed ID: 19471554
[TBL] [Abstract][Full Text] [Related]
20. Esophageal Metal Stents with Concurrent Chemoradiation Therapy for Locally Advanced Esophageal Cancer: Safe or Not?
Lu YF; Chung CS; Liu CY; Shueng PW; Wu LJ; Hsu CX; Kuo DY; Hou PY; Chou HL; Leong KI; How CH; Chou SF; Wang LY; Hsieh CH
Oncologist; 2018 Dec; 23(12):1426-1435. PubMed ID: 29728468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
